MED Medifast Inc

  1. Stocks
  2. Consumer Cyclical
  3. NYSE: MED

Price (delayed)

$82.1

Market cap

$893.84M

P/E Ratio

6.38

Dividend/share

$6.57

EPS

$12.87

Enterprise value

$794.47M

Medifast is the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, which offers scientifically developed products, clinically proven plans and the support of Coaches and a ...

Highlights
The price to earnings (P/E) is 68% less than the 5-year quarterly average of 20.2 and 34% less than the last 4 quarters average of 9.6
The company's quick ratio has surged by 52% QoQ and by 40% YoY
The equity has contracted by 21% YoY but it has grown by 10% from the previous quarter
MED's net income is down by 14% YoY
The EPS has declined by 9% year-on-year
Sector: Consumer Cyclical
Industry: Personal Services
Website: http://www.medifast1.com
Peers: WTW ABEO

Key stats

What are the main financial stats of MED
Market
Shares outstanding
10.89M
Market cap
$893.84M
Enterprise value
$794.47M
Valuations
Price to earnings (P/E)
6.38
Price to book (P/B)
5.21
Price to sales (P/S)
0.58
EV/EBIT
4.34
EV/EBITDA
3.96
EV/Sales
0.52
Earnings
Revenue
$1.53B
EBIT
$183.2M
EBITDA
$200.56M
Free cash flow
$199.17M
Per share
EPS
$12.87
Free cash flow per share
$18.33
Book value per share
$15.76
Revenue per share
$140.83
TBVPS
$29.6
Balance sheet
Total assets
$321.61M
Total liabilities
$150.71M
Debt
$24.38M
Equity
$170.9M
Working capital
$98.58M
Liquidity
Debt to equity
0.14
Current ratio
1.75
Quick ratio
0.94
Net debt/EBITDA
-0.5
Margins
EBITDA margin
13.1%
Gross margin
70.9%
Net margin
9.3%
Operating margin
12%
Efficiency
Return on assets
43.5%
Return on equity
93.6%
Return on invested capital
152.1%
Return on capital employed
96.5%
Return on sales
12%
Dividend
Dividend yield
8%
DPS
$6.57
Payout ratio
51%

MED stock price

How has the Medifast stock price performed over time
Intraday
-0.77%
1 week
-8.75%
1 month
-9.97%
1 year
-50.99%
YTD
-28.83%
QTD
-20.81%

Financial performance

How have Medifast's revenue and profit performed over time
Revenue
$1.53B
Gross profit
$1.08B
Operating income
$183.23M
Net income
$141.75M
Gross margin
70.9%
Net margin
9.3%
The operating income fell by 16% YoY
MED's net income is down by 14% YoY
Medifast's operating margin has decreased by 12% YoY but it has increased by 3.4% QoQ
Medifast's net margin has decreased by 10% YoY but it has increased by 3.3% from the previous quarter

Growth

What is Medifast's growth rate over time

Valuation

What is Medifast stock price valuation
P/E
6.38
P/B
5.21
P/S
0.58
EV/EBIT
4.34
EV/EBITDA
3.96
EV/Sales
0.52
The price to earnings (P/E) is 68% less than the 5-year quarterly average of 20.2 and 34% less than the last 4 quarters average of 9.6
The EPS has declined by 9% year-on-year
MED's P/B is 59% below its 5-year quarterly average of 12.8 and 46% below its last 4 quarters average of 9.7
The equity has contracted by 21% YoY but it has grown by 10% from the previous quarter
The P/S is 74% lower than the 5-year quarterly average of 2.2 and 36% lower than the last 4 quarters average of 0.9
MED's revenue is down by 4.6% year-on-year and by 4.3% since the previous quarter

Efficiency

How efficient is Medifast business performance
The return on invested capital has declined by 26% year-on-year but it rose by 12% since the previous quarter
MED's ROE is up by 15% YoY and by 6% QoQ
The return on sales has declined by 12% year-on-year but it has increased by 3.4% since the previous quarter
The ROA has increased by 6% from the previous quarter and by 2.6% YoY

Dividends

What is MED's dividend history
Dividend details
DPS
$6.57
Dividend yield
8%
Payout ratio
51%
Recent dividends

Financial health

How did Medifast financials performed over time
The total assets is 113% greater than the total liabilities
The company's quick ratio has surged by 52% QoQ and by 40% YoY
Medifast's total liabilities has decreased by 27% YoY and by 6% QoQ
Medifast's debt is 86% less than its equity
The equity has contracted by 21% YoY but it has grown by 10% from the previous quarter
Medifast's debt has decreased by 21% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.